LIVIA 2.0 was developed relying on theoretical and empirical findings on bereavement processes and WBIs, and is compared with LIVIA 1, which has already demonstrated its efficacy. We conducted a randomised controlled trial and provided on-demand guidance to participants. Outcomes were assessed exclusively through online questionnaires at pretest, posttest (12 weeks later), and follow-up (24 weeks later). Primary outcomes are grief symptoms, depressive symptoms, and eudemonic well-being. Secondary outcomes are anxiety symptoms, grief coping strategies, aspects related to self-identity reorganization, and program satisfaction. After the initial screening, the receipt of the signed ICF, and the completion of the T0 assessment, participants are randomized to one of the two IBIs and start the 12-weeks intervention. Then, they complete a post-test (T1) and follow-up assessment (T2). All the measures are self-report questionnaires + one weekly monitoring of mood and grief symptoms during the 12 weeks of the intervention. The questionnaires are sent to participants using the REDCap platform.
Two types of data are collected during the study: responses to the REDCap questionnaires (T0, T1, T2 and monitoring), as well as the participants' journey through the LIVIA 1 and LIVIA 2 programs.
